Advertisement

Tourette Syndrome

  • Andrea E. CavannaEmail author
  • Cristiano Termine
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 724)

Abstract

Tourette syndrome (TS) is a neurodevelopmental disorder consisting of multiple motor and one or more vocal/phonic tics. TS is increasingly recognized as a common neuropsychiatric disorder usually diagnosed in early childhood and comorbid neuropsychiatric disorders occur in approximately 90% of patients, with attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD) being the most common ones. Moreover, a high prevalence of depression and personality disorders has been reported. Although the mainstream of tic management is represented by pharmacotherapy, different kinds of psychotherapy, along with neurosurgical interventions (especially deep brain stimulation, DBS) play a major role in the treatment of TS. The current diagnostic systems have dictated that TS is a unitary condition. However, recent studies have demonstrated that there may be more than one TS phenotype. In conclusion, it appears that TS probably should no longer be considered merely a motor disorder and, most importantly, that TS is no longer a unitary condition, as it was previously thought. Neurodegenerative Diseases, edited by Shamim I. Ahmad.

Keywords

Attention Deficit Hyperactivity Disorder Deep Brain Stimulation Personality Disorder Attention Deficit Hyperactivity Disorder Tourette Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000; 123:425–462.PubMedCrossRefGoogle Scholar
  2. 2.
    Robertson MM, Cavanna AE. Tourette Syndrome: The Facts. 2nd ed. Oxford: Oxford University Press, 2008.Google Scholar
  3. 3.
    Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008;65(5):461–72.PubMedCrossRefGoogle Scholar
  4. 4.
    Robertson MM. Diagnosing Tourette Syndrome: Is it a common disorder? J Psychosom Res 2003; 55:3–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Staley D, Wand R, Shady G. Tourette disorder: a cross-cultural review. Compr Psychiatry 1997; 38:6–16.PubMedCrossRefGoogle Scholar
  6. 6.
    Kurlan R, McDermott MP, Deeley C et al. Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001; 57:1383–1388.PubMedGoogle Scholar
  7. 7.
    Baron-Cohen S, Scahill VL, Izaguirre J et al. The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study. Psychol Med 1999; 29:1151–1159.PubMedCrossRefGoogle Scholar
  8. 8.
    Robertson MM. Tourette syndrome. In: Skuse D, ed. Child Psychiatry IV. Oxford: The Medicine Publishing Company Group, Psychiatry 2005; 4:92–97.CrossRefGoogle Scholar
  9. 9.
    Mink JW. Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs. Adv Neurol 2006; 99:89–98.PubMedGoogle Scholar
  10. 10.
    Keen-Kim D, Freimer NB. Genetics and epidemiology of Tourette’s syndrome. J Child Neurol 2006; 21:665–671PubMedCrossRefGoogle Scholar
  11. 11.
    Abelson JF, Kwan KY, O'Roak BJ et al. Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science 2005; 310:317–320.PubMedCrossRefGoogle Scholar
  12. 12.
    Swedo SE, Leonard HL, Mittleman BB et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997; 154:110–112.PubMedGoogle Scholar
  13. 13.
    Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome and tic disorder. Pediatrics 2005; 116:56–60.PubMedCrossRefGoogle Scholar
  14. 14.
    Rizzo R, Gulisano M, Pavone P et al. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol 2006; 21:747–753.PubMedCrossRefGoogle Scholar
  15. 15.
    Leckman JF, Bloch MH, Scahill L et al. Tourette syndrome: the self under siege. J Child Neurol 2006; 21:642–649.PubMedCrossRefGoogle Scholar
  16. 16.
    Berardelli A, Currà A, Fabbrini G et al. Pathophysiology of tics and Tourette syndrome. J Neurol 2003; 250:781–787.PubMedCrossRefGoogle Scholar
  17. 17.
    Ludlow CL, Polinsky RJ, Caine ED et al. Language and speech abnormalities in Tourette syndrome. Adv Neurol 1982; 35:351–361.PubMedGoogle Scholar
  18. 18.
    Jankovic J. Phenomenology and classification of tics. In Jankovic J, ed. Neurologic Clinics. Philadelphia: WH Saunders Company, 1997; 267–275.Google Scholar
  19. 19.
    World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO, 1993.Google Scholar
  20. 20.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision (DSM-IV-TR). Washington, DC: APA, 2000.CrossRefGoogle Scholar
  21. 21.
    Robertson MM. The heterogeneous psychopathology of Tourette Syndrome. In: Bedard MA, Agid Y, Chouinard S et al, eds. Mental and Behavioral Dysfunction in Movement Disorders. New Jersey: Humana Press, Totowa, 2003:443–466.CrossRefGoogle Scholar
  22. 22.
    Packer LE. Social and educational resources for patients with Tourette syndrome. Neurol Clin 1997; 15:457–473.PubMedCrossRefGoogle Scholar
  23. 23.
    Freeman RD, Fast DK, Burd L et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000; 42:436–447.PubMedCrossRefGoogle Scholar
  24. 24.
    Khalifa N, von Knorring AL. Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background. Acta Paediatr 2005; 94:1608–1614.PubMedCrossRefGoogle Scholar
  25. 25.
    Cavanna AE, Servo S, Monaco F et al. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsy Clin Neurosci 2008; 21:13–23.CrossRefGoogle Scholar
  26. 26.
    Termine C, Balottin U, Rossi G et al. Psychopathology in children and adolescents with Tourette’s syndrome: a controlled study. Brain Dev 2006; 28:69–75.PubMedCrossRefGoogle Scholar
  27. 27.
    Singer HS, Brown J, Quaskey S et al. The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995; 95:74–81.PubMedGoogle Scholar
  28. 28.
    Spencer T, Biederman J, Harding M et al. Disentangling the overlap between Tourette’s disorder and ADHD. J Child Psychol Psychiatr 1998; 39:1037–1044.CrossRefGoogle Scholar
  29. 29.
    Stephens RJ, Sandor P. Aggressive behaviour in children with Tourette syndrome and comorbid attention-deficit hyperactivity disorder and obsessive-compulsive disorder. Can J Psychiatry 1999; 44:1036–1042.PubMedGoogle Scholar
  30. 30.
    Carter AS, O'Donnell DA, Schultz RT et al. Social and emotional adjustment in children affected with Gilles de la Tourette’s syndrome: associations with attention deficit hyperactivity disorder and family functioning. J Child Psychol Psychiatry 2000; 41:215–223.PubMedCrossRefGoogle Scholar
  31. 31.
    Sukhodolsky DG, Scahill L, Zhang H et al. Disruptive behavior in children with Tourette’s syndrome: association with ADHD comorbidity, tic severity and functional impairment. J Am Acad Child Adolesc Psychiatry 2003; 42:98–105.PubMedCrossRefGoogle Scholar
  32. 32.
    Pauls DL, Leckman J, Towbin KE et al. A possible genetic relationship exists between Tourette’s syndrome and obsessive-compulsive disorder. Psychopharmacol Bull 1986; 22:730–733.PubMedGoogle Scholar
  33. 33.
    Eapen V, Pauls D, Robertson M. Evidence for autosomal dominant transmission in Tourette’s syndrome. Br J Psychiatry 1993; 163:593–596.CrossRefGoogle Scholar
  34. 34.
    Robertson MM, Trimble MR, Lees AJ. The psychopathology of the Gilles de la Tourette syndrome: a phenomenological analysis. Br J Psychiatry 1988; 152:383–390.PubMedCrossRefGoogle Scholar
  35. 35.
    Frankel M, Cummings JL, Robertson MM et al. Obsessions and compulsions in Gilles de la Tourette’s syndrome. Neurology 1986; 36:378–382.PubMedGoogle Scholar
  36. 36.
    George MS, Trimble MR, Ring HA et al. Obsessions in obsessive compulsive disorder with and without Gilles de la Tourette syndrome. Am J Psychiatry 1993; 150:93–97.PubMedGoogle Scholar
  37. 37.
    Montgomery MA, Clayton PJ, Friedhoff AJ. Psychiatric illness in Tourette syndrome patients and first-degree relatives. Adv Neurol 1982; 35:335–340.PubMedGoogle Scholar
  38. 38.
    Robertson MM. Mood disorders and Gilles de la Tourette’s syndrome: an update on prevalence, etiology, comorbidity, clinical associations and implications. J Psychosom Res 2006; 61:349–358.PubMedCrossRefGoogle Scholar
  39. 39.
    Robertson MM. Attention deficit hyperactivity disorder, tics and Tourette’s syndrome: the relationship and treatment implications. Eur Child Adolesc Psychiatry 2006; 15:1–11.PubMedCrossRefGoogle Scholar
  40. 40.
    Elstner K, Selai CE, Trimble MR et al. Quality of Life (QOL) of patients with Gilles de la Tourette’s syndrome. Acta Psychiatr Scand 2001; 103:52–59.PubMedCrossRefGoogle Scholar
  41. 41.
    Salmon G, James A, Smith DM. Bullying in schools: self reported anxiety, depression and self esteem in secondary school children. Br Med J 1998; 317:924–925.CrossRefGoogle Scholar
  42. 42.
    Bond L, Carlin JB, Thomas L et al. Does bullying cause emotional problems? A prospective study of young teenagers. Br Med J 2001; 323:480–484.CrossRefGoogle Scholar
  43. 43.
    Shapiro AK, Shapiro ES, Bruun RD et al. Gilles de la Tourette syndrome. New York: Raven Press;1978.Google Scholar
  44. 44.
    Robertson M, Banerjee S, Fox-Hiley PJ et al. Personality disorder and psychopathology in Tourette’s syndrome: a controlled study. Br J Psychiatry 1997; 171:283–286.PubMedCrossRefGoogle Scholar
  45. 45.
    Cavanna AE, Robertson MM, Critchley HD. Schizotypal personality traits in Gilles de la Tourette syndrome. Acta Neurol Scand 2007; 116:385–391.PubMedCrossRefGoogle Scholar
  46. 46.
    Stern JS, Burza S, Robertson MM. Gilles de la Tourette’s syndrome and its impact in the UK. Postgrad Med J 2005; 81:12–19.PubMedCrossRefGoogle Scholar
  47. 47.
    Himle MB, Woods DW, Piacentini JC et al. Brief review of habit reversal training for Tourette syndrome. J Child Neurol 2006; 21:719–725.PubMedCrossRefGoogle Scholar
  48. 48.
    Freeman RD. Attention deficit hyperactivity disorder in the presence of Tourette syndrome. Neurol Clin 1997; 15:411–420.PubMedCrossRefGoogle Scholar
  49. 49.
    Tourette’s Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002; 58:527–536.Google Scholar
  50. 50.
    Ingrassia A, Turk J. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders—a case series. Eur Child Adolesc Psychiatry 2005; 14:34–40.PubMedCrossRefGoogle Scholar
  51. 51.
    Miguel EC, Shavitt RG, Ferrão YA et al. How to treat OCD in patients with Tourette syndrome. J Psychosom Res 2003; 55:49–57.PubMedCrossRefGoogle Scholar
  52. 52.
    Nestadt G, Samuels J, Riddle MA et al. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med 2001; 31:481–487.PubMedCrossRefGoogle Scholar
  53. 53.
    Milberger S, Biederman J, Faraone SV et al: Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry 1995; 152:1793–1799PubMedGoogle Scholar
  54. 54.
    Wilhelm S, Deckersbach T, Coffey BJ et al. Habit Reversal versus supportive therapy for Tourette’s disorder: a randomised controlled trial. American Journal of Psychiatry 2003; 160:1175–1177.PubMedCrossRefGoogle Scholar
  55. 55.
    Deckersbach T, Rauch S, Buhlmann U et al. Habit reversal versus supportive psychotherapy in Tourette’s disorder: a randomized controlled trial and predictors of treatment response. Behavioral Research Therapy 2006; 160:1175–1177.Google Scholar
  56. 56.
    Porta M, Maggioni G, Ottaviani F et al. Treatment of phonic tics in patients with Tourette’s syndrome using botulinum toxin type A. Neurological Sciences 2004; 24:420–423.PubMedCrossRefGoogle Scholar
  57. 57.
    Servello D, Porta M, Sassi M et al. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry 2008; 79:136–142.PubMedCrossRefGoogle Scholar
  58. 58.
    Rickards H, Wood C, Cavanna AE. Hassler and Dieckmann’s seminal paper on stereotactic thalamotomy for Gilles de la Tourette syndrome: translation and critical reappraisal. Mov Disord 2008; 23:1966–1972.PubMedCrossRefGoogle Scholar
  59. 59.
    Mathews CA, Jang KL, Herrera LD et al. Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations. Biol Psychiatry 2007; 61:292–300.PubMedCrossRefGoogle Scholar
  60. 60.
    Robertson MM, Cavanna AE. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree. Psychiatr Genet 2007; 17:143–152.PubMedCrossRefGoogle Scholar
  61. 61.
    Cavanna AE, Schrag A, Morley D et al. The Gilles de la Tourette syndrome-Quality of Life scale (GTS-QOL): development and validation. Neurology 2008; 71:1410–1416.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2012

Authors and Affiliations

  1. 1.Department of NeuropsychiatryUniversity of Birmingham and BSMHFTBirminghamUK
  2. 2.Sobell Department of Movement Disorders, Institute of NeurologyUCLLondonUK
  3. 3.Child Neuropsychiatry Unit, Department of Experimental MedicineUniversity of InsubriaVareseItaly

Personalised recommendations